Oramed Pharmaceuticals
ORMP
#9127
Rank
HK$0.88 B
Marketcap
HK$22.18
Share price
1.42%
Change (1 day)
18.01%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): HK$0.45 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are HK$2 Million. In 2024 the company made an earning of -HK$0.12 Billion a decrease over its 2023 earnings that were of HK$55.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$0.45 B-487.78%
2024 -HK$0.12 Billion-311.47%
2023 HK$55.46 M-119.45%
2022 -HK$0.29 Billion39.17%
2021 -HK$0.21 Billion73.93%
2020 -HK$0.12 Billion18.53%
2019 -HK$99.37 Million-16.62%
2018 -HK$0.12 Billion38.32%
2017 -HK$86.16 Million12.51%
2016 -HK$76.58 Million25.01%
2015 -HK$61.26 Million18.18%
2014 -HK$51.84 Million39.72%
2013 -HK$37.11 Million46.4%
2012 -HK$25.35 Million128.32%
2011 -HK$11.1 Million-51.47%
2010 -HK$22.88 Million35.21%
2009 -HK$16.92 Million
2007 -HK$26.6 Million607.04%
2006 -HK$3.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-HK$4.04 Billion-989.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$162.26 B 35,654.86%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
HK$70.83 B 15,508.83%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
-HK$0.22 Billion-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
-HK$0.54 Billion-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA